相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Soluble Flt-1 as a diagnostic marker of pre-eclampsia
Jane Woolcock et al.
AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY (2008)
A compartment model of VEGF distribution in blood, healthy and diseased tissues
Marianne O. Stefanini et al.
BMC SYSTEMS BIOLOGY (2008)
Circulating vascular endothelial growth factor and its soluble receptors in patients with liver cirrhosis: Possible association with hepatic function impairment
Jerzy Jaroszewicz et al.
CYTOKINE (2008)
Angiogenic factors for the prediction of pre-eclampsia in women with abnormal midtrimester uterine artery Doppler velocimetry
Abdalla E. Diab et al.
INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS (2008)
Last Word on Point : Counterpoint: There is/is not capillary recruitment in active skeletal muscle during exercise
Michael Clark et al.
JOURNAL OF APPLIED PHYSIOLOGY (2008)
The VEGF receptor Flt-1 spatially modulates Flk-1 signaling and blood vessel branching
Nicholas C. Kappas et al.
JOURNAL OF CELL BIOLOGY (2008)
Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease
Clarence M. Findley et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2008)
Systems Biology of Vascular Endothelial Growth Factors
Feilim Mac Gabhann et al.
MICROCIRCULATION (2008)
A prospective, observational study of soluble FLT-1 and vascular endothelial growth factor in sepsis
Nathan I. Shapiro et al.
SHOCK (2008)
Skeletal muscle VEGF gradients in peripheral arterial disease: simulations of rest and exercise
James W. Ji et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Integrated approach to designing growth factor delivery systems
Ruth R. Chen et al.
FASEB JOURNAL (2007)
No difference in the skeletal muscle angiogenic response to aerobic exercise training between young and aged men
Timothy P. Gavin et al.
JOURNAL OF PHYSIOLOGY-LONDON (2007)
Src-mediated phosphorylation of hsp90 in response to vascular endothelial growth factor (VEGF) is required for VEGF receptor-2 signaling to endothelial NO synthase
Martine Duval et al.
MOLECULAR BIOLOGY OF THE CELL (2007)
Impaired angiogenesis after Hindlimb ischemia in type 2 diabetes Mellitus - Differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1
Surovi Hazarika et al.
CIRCULATION RESEARCH (2007)
Effects of acute exercise, exercise training, and diabetes on the expression of lymphangiogenic growth factors and lymphatic vessels in skeletal muscle
Riikka Kivela et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2007)
Acute resistance exercise increases skeletal muscle angiogenic growth factor expression
T. P. Gavin et al.
ACTA PHYSIOLOGICA (2007)
Molecular mapping and functional characterization of the VEGF164 heparin-binding domain
Dominik Krilleke et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Platelets take up the monoclonal antibody bevacizumab
Henk M. W. Verheu et al.
CLINICAL CANCER RESEARCH (2007)
Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting
Qi Pan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Soluble vascular endothelial growth factor receptor-1 protects mice in sepsis
Po-Nien Tsao et al.
CRITICAL CARE MEDICINE (2007)
Dimerization of VEGF receptors and implications for signal transduction: A computational study
Feilim Mac Gabhann et al.
BIOPHYSICAL CHEMISTRY (2007)
Soluble fms-like tyrosine kinase-1 expression inhibits the growth of multiple myeloma in nude mice
Junru Liu et al.
ACTA BIOCHIMICA ET BIOPHYSICA SINICA (2007)
Multi-scale computational models of pro-angiogenic treatments in peripheral arterial disease
Feilim Mac Gabhann et al.
ANNALS OF BIOMEDICAL ENGINEERING (2007)
Postischemic gene transfer of soluble Flt-1 protects against brain ischemia with marked attenuation of blood-brain barrier permeability
Yasuhiro Kumai et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2007)
Alternative splicing in angiogenesis: The vascular endothelial growth factor paradigm
Michael R. Ladomery et al.
CANCER LETTERS (2007)
VEGF and VEGFR-2 (KDR) internalization is required for endothelial recovery during wound healing
Susana Constantino Rosa Santos et al.
EXPERIMENTAL CELL RESEARCH (2007)
Antiangiogenic gene therapy with systemically administered sFlt-1 plasmid DNA in engineered gelatin-based nanovectors
S. Kommareddy et al.
CANCER GENE THERAPY (2007)
Combined effects of soluble vascular endothelial growth factor receptor FLT-1 gene therapy and cisplatin chemotherapy in human tongue carcinoma xenografts
Zhen-Nan Gao et al.
ORAL ONCOLOGY (2007)
Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier
Balamurali K. Ambati et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2007)
Vascular endothelial growth factors -: Biology and current status of clinical applications in cardiovascular medicine
Seppo Yla-Herttuala et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2007)
In mice with type 2 diabetes, a vascular endothelial growth factor (VEGF)-activating transcription factor modulates VEGF signaling and induces therapeutic angiogenesis after hindlimb ischemia
Yongjun Li et al.
DIABETES (2007)
Mapping the theories of preeclampsia and the role of angiogenic factors - A systematic review
Mariana Widmer et al.
OBSTETRICS AND GYNECOLOGY (2007)
Roles for VEGF in the adult
Arindel S. R. Maharaj et al.
MICROVASCULAR RESEARCH (2007)
Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches
Feilim Mac Gabhann et al.
PLOS COMPUTATIONAL BIOLOGY (2006)
Corneal avascularity is due to soluble VEGF receptor-1
Balamurali K. Ambati et al.
NATURE (2006)
VEGF regulates the mobilization of VEGFR2/KDR from an intracellular endothelial storage compartment
Alexandra Gampel et al.
BLOOD (2006)
Heparin-II domain of fibronectin is a vascular endothelial growth factor-binding domain - Enhancement of VEGF biological activity by a singular growth factor/matrix protein synergism
Errol S. Wijelath et al.
CIRCULATION RESEARCH (2006)
Anti-angiogenic inhibition of tumor growth by systemic delivery of PEI-g-PEG-RGD/pCMV-sFlt-1 complexes in tumor-bearing mice
Won Jong Kim et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Fabrication of endothelialized tube in collagen gel as starting point for self-developing capillary-like network to construct three-dimensional organs in vitro
Takayuki Takei et al.
BIOTECHNOLOGY AND BIOENGINEERING (2006)
Computational model of vascular endothelial growth factor spatial distribution in muscle and pro-angiogenic cell therapy
Feilim Mac Gabhann et al.
PLOS COMPUTATIONAL BIOLOGY (2006)
Heparin-mediated conformational changes in fibronectin expose vascular endothelial growth factor binding sites
Maria Mitsi et al.
BIOCHEMISTRY (2006)
Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartments
Maria Grazia Lampugnani et al.
JOURNAL OF CELL BIOLOGY (2006)
Interactions between heparan sulfate and proteins: the concept of specificity
Johan Kreuger et al.
JOURNAL OF CELL BIOLOGY (2006)
VEGF receptor signalling - in control of vascular function
AK Olsson et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)
Vesicular trafficking of tyrosine kinase receptors and associated proteins in the regulation of signaling and vascular function
S Mukherjee et al.
CIRCULATION RESEARCH (2006)
The role of VEGF receptors in angiogenesis;: complex partnerships
S Cébe-Suarez et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2006)
Pigment epithelium-derived factor inhibits angiogenesis via regulated intracellular proteolysis of vascular endothelial growth factor receptor 1 (Withdrawn Publication. See vol. 298, 2021)
J Cai et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Vascular endothelial growth factor localization in the adult
ASR Maharaj et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Heparan sulfates development in skeletal muscle and physiology
GJ Jenniskens et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2006)
VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase
CJ Robinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Lower skeletal muscle capillarization and VEGF expression in aged vs. young men
NA Ryan et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Intrinsic tyrosine kinase activity is required for vascular endothelial growth factor receptor 2 ubiquitination, sorting and degradation in endothelial cells
Lorna C. Ewan et al.
TRAFFIC (2006)
Lymphangiogenesis in development and human disease
K Alitalo et al.
NATURE (2005)
Imaging of angiogenesis in inflamed airways and tumors: Newly formed blood vessels are not alike and may be wildly abnormal - Parker B. Francis lecture
DM McDonald et al.
CHEST (2005)
Density and hydration of fresh and fixed human skeletal muscle
SR Ward et al.
JOURNAL OF BIOMECHANICS (2005)
Lower capillarization, VEGF protein, and VEGF mRNA response to acute exercise in the vastus lateralis muscle of aged vs. young women
AN Croley et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Arteriolization of capillaries and FGF-2 upregulation in skeletal muscles of patients with chronic peripheral arterial disease
O Baum et al.
MICROCIRCULATION (2005)
Basement membrane proteoglycans: From cellar to ceiling
RV Iozzo
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2005)
VEGF-A splice variants and related receptor expression in human skeletal muscle following submaximal exercise
T Gustafsson et al.
JOURNAL OF APPLIED PHYSIOLOGY (2005)
Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumors
S Lee et al.
JOURNAL OF CELL BIOLOGY (2005)
Suppression of tumor growth by oncolytic adenovirus-mediated delivery of an antiangiogenic gene, soluble Flt-1
ZL Zhang et al.
MOLECULAR THERAPY (2005)
Soluble VEGF/sFLt1 ratio is an independent predictor of AML patient out come
S Aref et al.
HEMATOLOGY (2005)
Vascular endothelial growth factor(VEGF)-A165-induced prostacyclin synthesis requires the activation of VEGF receptor-1 and-2 heterodimer
PE Neagoe et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Plasma levels and zymographic activities of matrix metalloproteinases 2 and 9 in type II diabetics with peripheral arterial disease
SS Signorelli et al.
VASCULAR MEDICINE (2005)
Antiangiogenic cancer gene therapy by adeno-associated virus 2-mediated stable expression of the soluble FMS-like tyrosine kinase-1 receptor
G Mahendra et al.
CANCER GENE THERAPY (2005)
The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions
H Takahashi et al.
CLINICAL SCIENCE (2005)
Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity
MH Tayebjee et al.
JOURNAL OF INTERNAL MEDICINE (2005)
Vascular endothelial growth factor (VEGF) and soluble VEGF receptor FLT-1 in diabetic nephropathy
NH Kim et al.
KIDNEY INTERNATIONAL (2005)
A reaction-diffusion model of basic fibroblast growth factor interactions with cell surface receptors
RJ Filion et al.
ANNALS OF BIOMEDICAL ENGINEERING (2004)
Circulating plasma VEGF response to exercise in sedentary and endurance-trained men
RM Kraus et al.
JOURNAL OF APPLIED PHYSIOLOGY (2004)
Characterization of growth factor-binding structures in heparin/heparan sulfate using an octasaccharide library
S Ashikari-Hada et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
sFlt-1 gene therapy of follicular thyroid carcinoma
CS Ye et al.
ENDOCRINOLOGY (2004)
Marked inhibition of retinal neovascularization in rats following soluble-flt-1 gene transfer
R Rota et al.
JOURNAL OF GENE MEDICINE (2004)
Intracerebral haemorrhage following carotid endarterectomy
DA Russell et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2004)
Therapeutic angiogenesis in peripheral arterial disease: Can biotechnology produce an effective collateral circulation?
DJ Collinson et al.
EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY (2004)
Elevated placental soluble vascular endothelial growth factor receptor-1 inhibits angiogenesis in preeclampsia
S Ahmad et al.
CIRCULATION RESEARCH (2004)
Transduction of soluble Flt-1 gene to peritoneal mesothelial cells can effectively suppress peritoneal metastasis of gastric cancer
A Sako et al.
CANCER RESEARCH (2004)
Angiogenesis, thrombogenesis, endothelial dysfunction and angiographic severity of coronary artery disease
NA Chung et al.
HEART (2003)
Adenoviral delivery of soluble VEGF receptor 1 (sFlt-1) abrogates disease activity in murine collagen-induced arthritis
AO Afuwape et al.
GENE THERAPY (2003)
Role of PIGF in the intra- and intermolecular cross talk between the VEGF receptors Flt1 and Flk1
M Autiero et al.
NATURE MEDICINE (2003)
Exercise but not prostanoids enhance levels of vascular endothelial growth factor and other proliferative agents in human skeletal muscle interstitium
L Höffner et al.
JOURNAL OF PHYSIOLOGY-LONDON (2003)
Basement membranes: Structure, assembly and role in tumour angiogenesis
R Kalluri
NATURE REVIEWS CANCER (2003)
Periocular gene transfer of sFlt-1 suppresses ocular neovascularization and vascular endothelial growth factor-induced breakdown of the blood-retinal barrier
P Gehlbach et al.
HUMAN GENE THERAPY (2003)
Physical activity in relation to indices of endothelial function and angiogenesis factors in hypertension: a substudy of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
DC Felmeden et al.
JOURNAL OF INTERNAL MEDICINE (2003)
Plasma vascular endothelial growth factor, soluble VEGF receptor FLT-1, and von Willebrand factor in glaucoma
PL Lip et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2002)
VEGF-Trap: A VEGF blocker with potent antitumor effects
J Holash et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans
SM Eppler et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2002)
Expression and endocytosis of VEGF and its receptors in human colonic vascular endothelial cells
DF Wang et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2002)
Vascular recruitment in skeletal muscle during exercise and hyperinsulinemia assessed by contrast ultrasound
D Dawson et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2002)
Current medical therapies for patients with peripheral arterial disease: A critical review
JG Regensteiner et al.
AMERICAN JOURNAL OF MEDICINE (2002)
Available space and extracellular transport of macromolecules: Effects of pore size and connectedness
F Yuan et al.
ANNALS OF BIOMEDICAL ENGINEERING (2001)
Muscle fiber characteristics in patients with peripheral arterial disease
MRM McGuigan et al.
MEDICINE & SCIENCE IN SPORTS & EXERCISE (2001)
Signaling properties of VEGF receptor-1 and-2 homo- and heterodimers
K Huang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2001)
Angiogenesis in cancer and other diseases
P Carmeliet et al.
NATURE (2000)
Treatment with soluble VEGF receptor reduces disease severity in murine collagen-induced arthritis
J Miotla et al.
LABORATORY INVESTIGATION (2000)
Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor:: In vivo expression and antitumor activity
ML Gagnon et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Release and complex formation of soluble VEGFR-1 from endothelial cells and biological fluids
C Hornig et al.
LABORATORY INVESTIGATION (2000)
Ultrastructural localization of the vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) receptor-2 (FLK-1, KDR) in normal mouse kidney and in the hyperpermeable vessels induced by VPF/VEGF-expressing tumors and adenoviral vectors
D Feng et al.
JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY (2000)
分享论文
